Seeking Alpha

Takeda found not liable in latest diabetes drug lawsuit

  • Takeda Pharmaceuticals (TKPHF, TKPYY) yesterday was found not liable for the bladder cancer of two women who used its Actos diabetes medication, as a Nevada jury agreed with the company that the drug did not cause the women’s disease.
  • A jury last month ordered Takeda and partner Eli Lilly (LLY) to pay more than $9B in damages to a plaintiff - Takeda is appealing the verdict - but the company has won the other five cases that have gone to trial over Actos' alleged link to bladder cancer.
  • Takeda still faces claims by more than 7,000 plaintiffs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: